glp-1 drugs for pcos Therapeutic Potential of Glucagon-like Peptide-1 Agonists in Polycystic Ovary Syndrome: From Current Clinical Evidence to Future Perspectives GLP-1 drugs for Polycystic Ovary

[DOI] [PMC free article] [PubMed] [Google Scholar] [18].Moran LJ, Noakes M, Clifton P, et al

Studies show that weight loss can lower total cholesterol levels in the body

NGs were excised from the mice anesthetized with -chloralose and urethane (0.1 and 1 g kg 1 , i.p.)

Staying informed and maintaining open communication with your healthcare team can help you make choices that support your health and hemophilia management

The observed association might also reflect ascertainment bias related to known side effects of GLP-1RAs, as common symptoms like nausea and dizziness may prompt investigations that uncover pre-existing vestibular conditions [44]

--- 5 Dosage Initial dose: 5 mg once daily (usually at bedtime) After 46 weeks Increase to 10 mg daily Severe cases: up to 23 mg daily (extended-release form) --- 6 Adverse Effects Common: Nausea Vomiting Diarrhea Insomnia Muscle cramps Fatigue Serious: Bradycardia Syncope GI bleeding QT prolongation (rare) Due to increased cholinergic activity